个股表现 2024-06 2024-08 2024-11 2025-01 2025-03 2025-06 -16% 5% 26% 47% 68% 89% 110% 131% 152% 173% 福光股份 电子 证券研究报告：电子 | 公司点评报告 股票投资评级 买入 |首次覆盖 | 最新收盘价（元） | 30.30 | | --- | --- | | 总股本/流通股本（亿股）1.61 | / 1.61 | | 总市值/流通市值（亿元）49 | / 49 | | 周内最高/最低价 52 | 44.30 / 12.95 | | 资产负债率(%) | 33.8% | | 市盈率 | 501.66 | | 第一大股东 | 中融(福建)投资有限公 | | 司 | | 研究所 分析师:吴文吉 SAC 登记编号:S1340523050004 Email:wuwenji@cnpsec.com 分析师:翟一梦 SAC 登记编号:S1340525040003 Email:zhaiyimeng@cnpsec.com 福光股份(688010) 半导体精密光学持续推进，车载镜头加速成长 l 投资要点 定制产品与非定制产品双轮驱动，深化 ...

Core Viewpoint - The company, Ningbo Yongxin Optical Co., Ltd., is undergoing significant developments in its financial reporting and strategic initiatives, including a proposed stock issuance to raise funds for business expansion and operational needs. Financial Performance - The company reported a revenue of 891.76 million yuan for the reporting period, reflecting a year-on-year growth of 4.41% [47] - Revenue from microscope products decreased by 13.92% to 356.46 million yuan, accounting for 39.97% of total revenue [47] - Revenue from optical components increased by 22.56% to 513.29 million yuan, representing 57.56% of total revenue [47] - The net profit attributable to shareholders was 208.58 million yuan, down 11.37% year-on-year, while the net profit excluding non-recurring gains and losses rose by 14.25% to 184.91 million yuan [47] Business Overview - The company operates primarily in the optical precision instrument sector, focusing on the research, development, production, and sales of optical microscopes and components [41] - Key products include biological microscopes, industrial microscopes, barcode scanner lenses, and precision optical components, with a strong export market in Europe, Japan, Singapore, and India [41] - The company has established itself as a leader in the domestic optical microscope industry and is expanding into emerging fields such as automotive optics, machine vision, and medical optics [41][42] Industry Context - The global optical microscope market is projected to reach 6.1 billion USD by 2026, driven by increased investment in life sciences and technological advancements [30] - The barcode scanning market is expected to grow from 7.87 billion USD in 2024 to 13.06 billion USD by 2032, with a compound annual growth rate (CAGR) of 7.5% [32] - The machine vision market is anticipated to grow from 13.9 billion USD in 2024 to 18.5 billion USD by 2028, with a CAGR of 7.4% [33] - The medical device market in China is projected to reach approximately 1.2 trillion yuan in 2024, with a CAGR of 14.5% [37] Strategic Initiatives - The company plans to issue stocks to raise up to 300 million yuan, not exceeding 20% of the net assets as of the end of the previous year, to fund business-related projects and supplement working capital [10][11] - The stock issuance will be conducted through a simplified procedure targeting specific investors, with a maximum issuance not exceeding 30% of the total share capital prior to the issuance [12][16] - The funds raised will be allocated to projects aligned with the company's main business and will comply with regulatory requirements [17]